Cerevel Therapeutics is a startup based in the United States, 2 tracked investors.
Based in the United States, Cerevel Therapeutics is a startup. Brouky records 2 investors associated with the company.
Cerevel Therapeutics is a biopharmaceutical company focused on developing and commercializing therapies for neuroscience disorders such as Parkinson's disease, schizophrenia, and other central nervous system conditions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.